Trials / Terminated
TerminatedNCT01363466
Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer
Randomized Phase III Trial Evaluating the Impact of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- UNICANCER · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
GYNECO 02 hypothesis is that hysterectomy reduces the possibility of local or loco-regional relapse, especially in patient with a reduced metastatic risk and who received a local chemoradiation therapy with an increase of radiotherapy doses (45 grays).
Conditions
- Stage IB2 Cervical Cancer
- Stage II Cervical Cancer
- Adenocarcinoma
- Squamous Cell Carcinoma
- Adenosquamous Carcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | hysterectomy |
Timeline
- Start date
- 2003-05-01
- Completion
- 2006-11-01
- First posted
- 2011-06-01
- Last updated
- 2011-06-01
Locations
35 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01363466. Inclusion in this directory is not an endorsement.